
European Journal of Pharmaceutics and Biopharmaceutics, Год журнала: 2025, Номер 213, С. 114758 - 114758
Опубликована: Май 26, 2025
Язык: Английский
European Journal of Pharmaceutics and Biopharmaceutics, Год журнала: 2025, Номер 213, С. 114758 - 114758
Опубликована: Май 26, 2025
Язык: Английский
Pharmaceuticals, Год журнала: 2025, Номер 18(3), С. 297 - 297
Опубликована: Фев. 21, 2025
Absorption and permeability are critical physicochemical parameters that must be balanced to achieve optimal drug uptake. These key factors closely linked the maximum absorbable dose required provide appropriate plasma levels of drugs. Among various strategies employed enhance solubility permeability, prodrug design stands out as a highly effective versatile approach for improving properties enabling optimization biopharmaceutical pharmacokinetic while mitigating adverse effects. Prodrugs compounds with reduced or no activity that, through bio-reversible chemical enzymatic processes, release an active parental drug. The application this technology has led significant advancements in during phase, it offers broad potential further development. Notably, approximately 13% drugs approved by U.S. Food Drug Administration (FDA) between 2012 2022 were prodrugs. In review article, we will explore describing examples market We also describe use optimize PROteolysis TArgeting Chimeras (PROTACs) using conjugation technologies. highlight some new technologies prodrugs enrich properties, contributing developing safe
Язык: Английский
Процитировано
0Bioorganic Chemistry, Год журнала: 2025, Номер 159, С. 108335 - 108335
Опубликована: Март 6, 2025
Язык: Английский
Процитировано
0Crystal Growth & Design, Год журнала: 2025, Номер unknown
Опубликована: Апрель 7, 2025
Язык: Английский
Процитировано
0Process Safety and Environmental Protection, Год журнала: 2025, Номер unknown
Опубликована: Май 1, 2025
Язык: Английский
Процитировано
0Crystal Growth & Design, Год журнала: 2025, Номер unknown
Опубликована: Май 13, 2025
Язык: Английский
Процитировано
0European Journal of Pharmaceutics and Biopharmaceutics, Год журнала: 2025, Номер 213, С. 114758 - 114758
Опубликована: Май 26, 2025
Язык: Английский
Процитировано
0